REQUEST A DEMO
Total
USD $0.00
Search more companies

Deshpande Drugs Private Limited (India)

Main Activities: Wholesale Electronic Markets and Agents and Brokers
Full name: Deshpande Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Deshpande Drugs Private Limited is based in India, with the head office in Bangalore. The enterprise currently operates in the Wholesale Electronic Markets and Agents and Brokers sector. It was established on October 05, 2015. There was a net sales revenue drop of 5.06% reported in Deshpande Drugs Private Limited’s latest financial highlights for 2025. Its’ total assets recorded a growth of 20.02%. In, 2025, the company’s net profit margin increased by 0.12%.

Legal Address
No. 25, 1St Floor, 4Th Main Road, Inbetween 2Nd & 3Rd Cross, Chamarajpet
Bangalore; Karnataka; Postal Code: 560018

Contact Details: Purchase the Deshpande Drugs Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Deshpande Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Deshpande Drugs Private Limited report to view the information.
Incorporation Date:
October 05, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Company Performance
Financial values in the chart are available after Deshpande Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.06%
Total Operating Revenue
-3.92%
Operating Profit
7.55%
EBITDA
7.15%
Net Profit/Loss for the Period
32.78%
Total Assets
20.02%
Total Equity
18.34%
Operating Profit Margin
0.19%
Net Profit Margin
0.12%
Return on Equity (ROE)
-8.65%
Debt / Equity
-270.34%
Quick Ratio
-0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?